Parametric Portfolio Associates’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Parametric Portfolio Associates’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,639	Closed	-$731K	–	3728
2021 Q2	$731K	Buy	21,639 +5,704	+36%	+$145K	﹤0.01%	2916
2021 Q1	$373K	Buy	+15,935	New	+$483K	﹤0.01%	3624

Parametric Portfolio Associates's CNST Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 21,639 shares — an estimated $731K sold.

Parametric Portfolio Associates first reported a position in CNST in Q1 2021 and held it in 2 quarters. The position peaked at $731K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Parametric Portfolio Associates reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 21,639 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $731K.
Parametric Portfolio Associates first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2021 and held it in 2 quarters.
Parametric Portfolio Associates's Constellation Pharmaceuticals, Inc. position peaked at $731K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.